Early Outcomes after Allogeneic Stem Cell Transplantation for Leukemia and Myelodysplasia Without Protective Isolation: A 10-Year Experience

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 2, 2000, Pages 109-114

  Russell, James A ^a,b,c   Chaudhry, Absan ^a   Booth, Karen ^b   Brown, Christopher ^a   Woodman, Richard C ^a   Valentine, Karen ^a   Stewart, Douglas ^a   Ruether, J Dean ^a   Ruether, Bernard A ^a   Jones, Allan R ^a   Coppes, Max J ^b   Bowen, Thomas ^b   Anderson, Ronald ^b   Bouchard, Marilyn ^a   Rallison, Lillian ^b   Stotts, Marion ^a   Poon, Man Chin ^a  

^a FOOTHILLS HOSPITAL   (Canada)

^b ALBERTA CHILDREN'S HOSPITAL   (Canada)

^c TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Infection; Isolation; Mortality; Transplantation

Indexed keywords

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; MALE; MORTALITY; MYCOSIS; MYELODYSPLASTIC SYNDROME; PATIENT CARE; SAFETY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BACTERIAL INFECTIONS; CHILD; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MYCOSES; MYELODYSPLASTIC SYNDROMES; PATIENT ISOLATION; SAFETY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0033631658     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70073-5     Document Type: Article

References (26)

1. Gamillscheg A, Urban C, Slave I, Lackner H, Mauer C. Infections in the neutropenic phase following bone marrow transplantation: comparison of laminar airflow isolation with conventional isolation. Wien Klin Wochenschr. 1991;103:82-87.
2. Schmeiser T, Kurrle E, Arnold R, Krieger D, Heit W, Heimpel H. Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation. Infection. 1991;16:19-24.
3. Buckner CD, Clift RA, Sanders JE, et al. Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med. 1978;89:893-901.
4. Petersen F, Thornquist M, Buckner C, et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection. 1988;16:199-208.
5. Heizmann W, Ehninger G, Vallbracht A, Botzenhart K. Surveillance cultures and benefit of laminar airflow units in patients undergoing bone marrow transplantation. Infection. 1987; 15:337-343.
6. Petersen FB, Buckner CD, Clift RA, et al. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scand J Infect Dis. 1987;19:559-567.
7. Mahmoud HK, Schaefer UW, Schuning F, et al. Laminar air flow versus barrier nursing in marrow transplant recipients. Blut. 1984;49:375-381.
8. Navari RM, Buckner CD, Clift RA, et al. Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants. Am J Med. 1984;6:564-572.
9. Passweg JR, Rowlings PA, Atkinson K, et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant. 1998;21:1231-1238.
10. Pretnar J, Cernelc P, Mlakar U. Infections in bone marrow transplant patients: use of reverse-barrier isolation. Transplant Proc. 1992;24:2033-2037.
11. Skinhoj P, Jacobsen N, Hoiby N, Faber V. Strict protective isolation in allogenic bone marrow transplantation: effect on infectious complications, fever and graft-versus-host disease. Scand J Infect Dis. 1987;19:91-96.
12. Zerbe MB, Parkerson SG, Spitzer T. Laminar air flow versus reverse isolation: nurses' assessments of moods, behaviors and activity levels in patients receiving bone marrow transplants. Oncol Nurs Forum. 1994;21:565-568.
13. Wald A, Leisenring W, van Burik J, Bowden R. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175:1459-1466.
14. Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant. 1993;12:121-124.
15. Sherertz RJ, Belani A, Kramer BS, et al. Impact of air filtration on nosocomial Aspergillus infections: unique risk of bone marrow transplant recipients. Am J Med. 1987;83:709-718.
16. Russell JA, Poon MC, Jones AR, Woodman RC, Ruether BA. Allogeneic bone marrow transplantation for adults with malignancy without protective isolation. Lancet. 1992;339:38-40.
17. Rizzo DJ. New summary slides show current trends in BMT. ABMTR Newsletter. 1998;5:4-10.
18. Russell JA, Woodman RC, Poon MC, Jones AR, Ruether BA. Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease. Bone Marrow Transplant. 1994;14:397-401.
19. Russell JA. Outpatient management. In: Barrett J, Treleaven J, eds. The Clinical Practice of Stem Cell Transplantation. Oxford, UK: Isis Medical Media; 1998.
20. Wingard JR. Infections in allogeneic bone marrow transplant recipients. Semin Oncol. 1993;20(5 suppl 6):80-87.
21. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995;20:115-125.
22. Sayer HG, Longton G, Bowden R, Pepe M, Storb R. Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention. Blood. 1994;84:1328-1332.
23. Morrison VA, Haake RJ, Weisdorf DJ. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am J Med. 1994;96:497-503.
24. Frassoni F, Labopin M, Gluckman, et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - a report of the acute leukemia-working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant. 1996;17:13-18.
25. Russell JA, Brown C, Bowen T, et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant. 1996;17:703-708.
26. Russell JA, Larratt L, Brown C, et al. Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome. Bone Marrow Transplant. 1999;24:1177-1183.